DrugLogic

PRESS RELEASE
Reston, VA.

GPRD & DrugLogic sign Data License Agreement
‘GPRD licensees can now use the powerful analytical capabilities of the Qscan patented products’

GPRD of London, suppliers of the General Practice Research Database, and DrugLogic Inc. of Reston VA have announced their collaboration to provide a version of GPRD that integrates with DrugLogic’s Qscan analysis software. GPRD is the world’s largest, most validated database of longitudinal electronic health records of some 5 million active patients from over 600 GP practices in the UK.

Under the agreement GPRD will allow DrugLogic to format and code the GPRD database so that it can be analysed by Qscan’s statistical engines. Users can structure queries to analyse the data across multiple parameters such as condition, age, gender, family history, treatments, outcomes and many more. The online system provides differential analysis (e.g. to compare drugs and diagnosis, or reaction and drugs for different demographics) of the GPRD data.

“Understanding post-market patient reactions to drugs are an important component of modern healthcare. While there are other means to generate alerts to drug risks, the depth and breadth of the GPRD longitudinal data can lead to a fuller understanding of drug behaviour, especially as we enter an era of personalized medicine, “ said Victor Gogolak, President of DrugLogic. “We are tremendously excited to be partnering with a leading provider of anonymized medical data.”

GPRD licensees can now use the powerful analytical capabilities of the Qscan patented products for their health research and pharmacovigilance systems. Organisations without GPRD licenses can access parts of the dataset to run analyses and generate reports for domains of therapeutic interest.

Qscan already enables analysis of ADR databases such as FDAs AERS/VAERs and the Yellow Card data which are used to generate alerts and hypotheses that can then be tested using the GPRD’s 5 million anonymised electronic patient records.

From a single online application pharmaceutical companies can now set up multiple views of their areas of therapeutic interest for deep analysis contributing to Risk Management Plans and pharmacovigilance systems.

Editors Notes:

About GPRD

The GPRD database can provide data from anonymised longitudinal medical records in primary care. Managed by the MHRA, it contains comprehensive observational data from real life clinical practice and provides analytical insight for a wide range of applications in clinical trial, drug safety, outcomes research and clinical epidemiology. www.gprd.com

The General Practice Research Database Group
The Medicines and Healthcare products Regulatory Agency
5th Floor
151 Buckingham Palace Road
Victoria
London SW1W 9SZ,
England

Contact

Jon Ford
GPRD Head of Operations
+44 20 3080 6581
jon.ford@gprd.com

About DrugLogic®, Inc.

DrugLogic®, Inc. specializes in developing analytical tools and enterprise process support systems for managing risks related to drug safety issues. DrugLogic designs, develops and delivers products that provide the latest innovations and state-of-the art solutions in support of patient and drug safety surveillance practices for Health Care and Pharmaceutical enterprises. Its proprietary Qscan® product monitors both patient, adverse event, claims, outcomes and publicly available data sources. For more information, visit www.druglogic.com

DrugLogic Offices:

Headquarters
11490 Commerce Park Drive
Suite 320
Reston, Virginia 20191
(703)-821-3200 (telephone)
(703) 821-0600 (fax)

Sales and Marketing

Call TOLL FREE 1-800-393-1313

or

Paul Zapert
978-557-0711
pzapert@druglogic.com

Europe
Steve Mott
+44 7525 760 724
smott@druglogic.co.uk